UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1142-1151

2008

Volltextzugriff (PDF)

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (3), p.283-288

2005

Volltextzugriff (PDF)

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

Journal of antimicrobial chemotherapy, 2009-12, Vol.64 (6), p.1130-1138

2009

Volltextzugriff (PDF)

Structure–Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea

Journal of medicinal chemistry, 2015-06, Vol.58 (12), p.5137-5142

2015

Volltextzugriff (PDF)

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone

Annals of clinical microbiology and antimicrobials, 2014-09, Vol.13 (1), p.46-46, Article 46

2014

Volltextzugriff (PDF)

Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein

Pediatrics (Evanston), 1999-12, Vol.104 (6), p.1327-1333

1999

Volltextzugriff (PDF)

Multicenter Evaluation of the Etest and Disk Diffusion Methods for Differentiating Daptomycin-Susceptible from Non-Daptomycin-Susceptible Staphylococcus aureus Isolates

Journal of Clinical Microbiology, 2006-09, Vol.44 (9), p.3098-3104

2006

Volltextzugriff (PDF)

In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin

International journal of antimicrobial agents, 2006-11, Vol.28 (5), p.385-388

2006

Volltextzugriff (PDF)

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis

Journal of antimicrobial chemotherapy, 2005-04, Vol.55 (4), p.574-578

2005

Volltextzugriff (PDF)

Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab™ prediffusion method

Diagnostic microbiology and infectious disease, 2008-07, Vol.61 (3), p.315-320

2008

Volltextzugriff (PDF)

Daptomycin In Vitro Susceptibility Methodology: a Review of Methods, Including Determination of Calcium in Testing Media

Clinical microbiology newsletter, 2010-11, Vol.32 (21), p.161-169

2010

Volltextzugriff (PDF)

Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke

Cochrane database of systematic reviews, 2008-01 (4), p.CD001746

2008

Volltextzugriff (PDF)

Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection

Antimicrobial Agents and Chemotherapy, 2003-11, Vol.47 (11), p.3561-3566

2003

Volltextzugriff (PDF)

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates

Diagnostic microbiology and infectious disease, 2008-07, Vol.61 (3), p.339-342

2008

Volltextzugriff (PDF)

Surotomycin Demonstrates Low In Vitro Frequency of Resistance and Rapid Bactericidal Activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faecium

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.3976-3982

2014

Volltextzugriff (PDF)

Chronic Parvovirus B19 Infection Resulting in Chronic Fatigue Syndrome: Case History and Review

Clinical infectious diseases, 1997-06, Vol.24 (6), p.1048-1051

1997

Volltextzugriff (PDF)

Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus

Diagnostic microbiology and infectious disease, 2009-11, Vol.65 (3), p.306-311

2009

Volltextzugriff (PDF)

Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis

Pediatric nephrology (Berlin, West), 1997-08, Vol.11 (4), p.488-490

1997

Volltextzugriff (PDF)

Daptomycin: a novel lipopeptide antibiotic

Clinical microbiology newsletter, 2002-03, Vol.24 (5), p.33-40

2002

Volltextzugriff (PDF)

Neonatal herpes simplex virus infection presenting as fulminant liver failure

The Pediatric infectious disease journal, 1995-03, Vol.14 (3), p.242-243

1995

Volltextzugriff (PDF)

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia. Commentary

Clinical infectious diseases, 2008, Vol.46 (8), p.1142-1156

2008

Volltextzugriff (PDF)

Diagnostic tests in gastrointestinal infections

Current opinion in gastroenterology, 1992-02, Vol.8 (1), p.134-144

Thorne, Grace M

1992

Volltextzugriff (PDF)

Parvovirus B19‐associated interstitial lung disease, hepatitis, and myositis

Pediatric pulmonology, 1998-11, Vol.26 (5), p.365-369

1998

Volltextzugriff (PDF)

Performance of a solid phase enzyme immunoassay for detection of group A streptococci in a pediatric office laboratory as refereed by a hospital laboratory

The Pediatric infectious disease journal, 1988-06, Vol.7 (6), p.393-397

1988

Volltextzugriff (PDF)

R Factor-Mediated Antibiotic Resistance in Serratia marcescens

Antimicrobial Agents and Chemotherapy, 1976-07, Vol.10 (1), p.123-127

1976

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(145)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

Structure–Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea

Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone

Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein

Multicenter Evaluation of the Etest and Disk Diffusion Methods for Differentiating Daptomycin-Susceptible from Non-Daptomycin-Susceptible Staphylococcus aureus Isolates

In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis

Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab™ prediffusion method

Daptomycin In Vitro Susceptibility Methodology: a Review of Methods, Including Determination of Calcium in Testing Media

Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke

Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection

In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates

Surotomycin Demonstrates Low In Vitro Frequency of Resistance and Rapid Bactericidal Activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faecium

Chronic Parvovirus B19 Infection Resulting in Chronic Fatigue Syndrome: Case History and Review

Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus

Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis

Daptomycin: a novel lipopeptide antibiotic

Neonatal herpes simplex virus infection presenting as fulminant liver failure

Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia. Commentary

Diagnostic tests in gastrointestinal infections

Parvovirus B19‐associated interstitial lung disease, hepatitis, and myositis

Performance of a solid phase enzyme immunoassay for detection of group A streptococci in a pediatric office laboratory as refereed by a hospital laboratory

R Factor-Mediated Antibiotic Resistance in Serratia marcescens

Suchergebnisse filtern